Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function

Tongji University60 enrolled

Overview

The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus clearance devices in elders of gerocomium.

Respiratory diseases are still increasing in the elderly population. The fluttering mucus clearance technique is expected to be a physical assisting therapy enhancing airway secretion clearance but needs more clinical randomized, controlled trial evidence.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Pulmonary Disease

Interventions

flutter mucus clearance deviceDEVICE

five minutes every sessions, three sessions per day

Eligibility

Sex: ALLMin age: 85 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * available to perform the device, the elders in geracomium * male and female * aging 85 years or more Exclusion Criteria: * not available to perform the procedure * untreated pneumothorax * diffusion interstitial lung disease * acute coronary syndrome * third stage hypertension * advanced cancer * severe heart, liver, renal, blood system and endocrine system dysfunction * noninvasive mechanical ventilation * active hemoptysis

Outcomes

Primary Outcomes

Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher)

Time frame: up to 28 days

MPEF,Mean Peak Expiratory Flow

indicators of pulmonary function, for example, PEF(unit of measurement:Liter per minute) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.

Time frame: up to 28 days

FEV1, Forced Expiratory Volume at First Second

indicators of pulmonary function, for example, FEV1(unit of measurement:Liter) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.

Time frame: up to 28 days

FVC, Forced Vital Capacity

indicators of pulmonary function, for example, FVC(unit of measurement:Liter) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.

Time frame: up to 28 days

FEV1/FVC%, the Ratio of FEV1 to FVC

indicators of pulmonary function, All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.

Time frame: up to 28 days

Secondary Outcomes

Number of Cases With Antibiotics Therapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.